by Anita Arguello and Brian Gallagher Brandy McCoy runs The Rose Tattoo, a tattoo studio in Layfayette, Indiana, with her husband Josh. She has been researching and advocating for CBD for the past decade and taking CBD daily for over a year, and also gives it to her pets. Brandy has also volunteered with the Read more about CBD Stories: Interview with Brandy McCoy from Indiana[…]
Cannabis has a long history of being used for a variety of purposes, from hemp oils and fibres to medicinal purposes. It became acknowledged and accepted into American pharmacopoeia, where it was evaluated for treating diseases, or the accompanying symptoms, until the early 1940s. […]
Last week, the Republican debate took a turn to focus on marijuana laws in the US. Moderator Jake Tapper took to a question popular on social media, asking about candidates views on marijuana legalization. He quoted Governor Christie, who recently said ‘if you’re getting high in Colorado today,’ where marijuana has been legalized, ‘enjoy it until January 2017, Read more about The Politics Of Medical Marijuana Takes Front Stage[…]
Dr. Nora Volkow, director of the National Institute on Drug Abuse, recently stepped forward to help clarify some of the misinformation circling marijuana and cannabidiol. As one of the world’s top experts on the application and misuse of cannabis and research, Volkow believes “what we can say with certainty is that cannabis contains active ingredients with potential therapeutic properties. […]
Last Friday, Michigan’s Medical Marijuana Review Panel voted to add autism to the list of qualifying conditions fit for treatment under state law.
Mike Zimmer, director of the Michigan Department of Licensing and Regulatory Affairs, is the next step in the process for approval. Zimmer has until late October to make a final decision. Once a final determination is made it will be announced on the agency’s website. […]
Over the past few months, from local community halls to Capitol Hill, one thing has been made clear: there is an outcry of support in favor of more research on CBD and medical marijuana. Proponents of CBD oil state that removing these barriers to research is the only clear way to market something so significant to families around the world.
Earlier this year, Democrat Sen. Diane Feinstein (CA) and Republican Sen. Charles Grassley (IA) urged the Obama administration to “definitively determine if CBD has scientific and medical benefits,” and to “look at expanding compassionate access programs where possible, to benefit as many children as possible.”
Recently, support has also come out from the director of the US National Institute on Drug Abuse (NIDA), Nora Volkow. Volkow believes that cannabidiol (CBD) – a nonpsychotropic cannabinoid – is “a safe drug with no addictive effects.” In a column with The Huffington Post, she further stated that“[P]reliminary data suggest that it may have therapeutic value for a number of medical conditions.”
With all of the talk going on around the country, is there any action behind these promises? […]